Regenerative & pain · Evidence
Do stem cell injections work? A physician’s review of the evidence
“Does it work?” deserves a better answer than a testimonial. This is how the evidence looks, condition by condition, from a physician who offers regenerative care and still tells most patients to start somewhere else.
Short answer
Not reliably, based on current evidence. Some patients improve after stem cell injections, but in the best-controlled trials they have generally not outperformed standard injections or placebo, and no product is FDA-approved for orthopedic or pain use. The honest answer is “possibly, for some people, for some conditions — and we cannot predict who.”
What “it works” should mean
A therapy “works” when people who receive it do meaningfully better than similar people who receive a comparison — ideally a placebo or the current standard — measured the same way over a meaningful period. That standard matters for pain especially, because pain naturally fluctuates, many conditions improve with time, and expectation alone produces real, measurable relief. In knee osteoarthritis trials, saline injections routinely reduce pain substantially.1
That is why a clinic’s video testimonials, satisfaction surveys and “90% success rates” cannot answer the question. They lack a comparison group.
Knee osteoarthritis
This is the best-studied use. A 480-patient randomized trial found that bone-marrow, fat-derived and umbilical-cord cell injections did not outperform a corticosteroid injection at 12 months.2 Smaller early-phase trials report encouraging signals but cannot establish effectiveness.3 The American College of Rheumatology recommends against stem cell injections for knee and hip osteoarthritis.4 The knee evidence in detail.
Shoulder and rotator cuff
Trials of cell injections for partial rotator cuff tears and tendinopathy are small, with short follow-up and inconsistent comparisons. Some report improvement from baseline, but improvement is also seen in control groups. The evidence is not strong enough to say cell injections are better than a structured rehabilitation program. Stem cells for shoulder pain.
Tendons and sports injuries
Most tendon research involves PRP rather than cells, and it is mixed: positive in some elbow trials, negative in randomized Achilles trials.5 Cell-based tendon trials remain early. For most tendon problems, progressive loading exercise is the foundation. Tendon & ligament care.
Back pain and discs
Injecting cells into degenerated discs has been studied in early trials with small numbers of patients, and results have not established benefit over control groups. Back pain has many possible sources, and injections into the disc carry specific risks. We do not recommend them outside well-designed studies. Back & neck pain.
Is it at least safe?
In controlled trials using carefully prepared products, serious adverse events have been uncommon and short-term side effects are mostly injection pain and swelling. Outside trials, the FDA has documented serious harms — including infections and blindness — from unapproved products and unsuitable uses, which is why product sourcing, the procedure and the indication matter so much.6,7 Long-term safety data remain limited.
How that evidence shapes care at PrimeCell
- We start with the diagnosis and with options that have better evidence.
- When a cell-based product is discussed, we say plainly that it is not FDA-approved, share what trials show for your condition, and provide the Florida disclosure and consent in writing.
- We track patient-reported pain and function after every procedure in our Outcomes Follow-Up program, and will not publish results until they can be reported honestly.
- We would rather lose a sale than sell a procedure we do not expect to help you.
How to judge any clinic’s claims
- Ask what randomized trials — not testimonials — show for your specific condition.
- Ask for the product’s regulatory status in writing.
- Be wary of cure language, cartilage-regrowth promises, prepaid packages and seminar pricing.
- Check whether a therapy is part of a registered trial at ClinicalTrials.gov.
Frequently asked questions
Why do some patients say stem cell injections worked for them?
Their improvement can be real. It may come from the injection, from natural recovery, from the rehabilitation that followed, or from the strong placebo response seen in pain trials. Only controlled trials can separate these.
Are stem cell injections a scam?
Not inherently. They are investigational therapies with real scientific interest behind them. The problem is marketing that overstates evidence or implies FDA approval. Clear disclosure and realistic expectations are what separate responsible care from hype.
Are exosomes better than stem cells?
There is no good evidence of that. Exosome products are not FDA-approved for any use, and their evidence for pain is even earlier. Exosomes explained.
What should I try first?
Usually a precise diagnosis, then rehabilitation and conventional options matched to that diagnosis. Weight management, when relevant, can reduce load on painful joints.
References
- Bennell KL, Paterson KL, Metcalf BR, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. JAMA. 2021;326(20):2021-2030. doi:10.1001/jama.2021.19415
- Mautner K, Gottschalk M, Boden SD, et al. Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med. 2023;29:3120-3126. doi:10.1038/s41591-023-02632-w
- Matas J, Orrego M, Amenabar D, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: a controlled randomized phase I/II trial. Stem Cells Transl Med. 2019;8(3):215-224. doi:10.1002/sctm.18-0053
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 ACR/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2020;72(2):149-162. doi:10.1002/acr.24131
- Kearney RS, Ji C, Warwick J, et al. Effect of platelet-rich plasma injection vs sham injection on tendon dysfunction in patients with chronic midportion Achilles tendinopathy: a randomized clinical trial. JAMA. 2021;326(2):137-144. doi:10.1001/jama.2021.6986
- Kuriyan AE, Albini TA, Townsend JH, et al. Vision loss after intravitreal injection of autologous “stem cells” for AMD. N Engl J Med. 2017;376(11):1047-1053. doi:10.1056/NEJMoa1609583
- U.S. Food and Drug Administration. Consumer alert on regenerative medicine products including stem cells and exosomes. fda.gov
General education, not medical advice. No stem cell or exosome product is FDA-approved for orthopedic or pain conditions. Candidacy is determined at an individual evaluation; results vary and are not guaranteed.